Enovis | ENOV - Umsatzkosten

Aktienkurs
25.30
Täglich Wechseln
0.20 0.80%
Monatlich
9.00%
Jährlich
-18.81%
Q2 Prognose
23.75




Umsatzkosten Veränderung Datum
Alcidion AUD 6.82M 1.16M 2025-12
Ambu A/S DKK 611M 24M 2025-12
Amplifon EUR 460.17M 14.78M 2025-09
Apollo Hospitals Enterprise Ltd INR 36.02B 1.4B 2025-12
Coloplast 2.31B 110M 2025-12
Convatec Group USD 515.3M 270.15M 2024-12
Diasorin EUR 99.64M 4.71M 2025-09
Enovis USD 271.52M 7.83M 2025-12
Gulf Medical Proj AED 151.05M 11.52M 2025-12
Hoya 33.74B 138.33B 2025-12
Med Life RON 283.78M 123.71M 2025-09
Oriola-kd EUR 461.6M 35.5M 2025-12
Rede D'or Sao Luiz BRL 6.29B 4.77B 2025-12
Siemens Healthineers EUR 3.33B 622M 2025-12
Sonova Holding CHF 539.4M 11.5M 2025-12